Phibro Animal Health Corporation (PAHC) - Stock Analysis
Last updated: Jun 7, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong liquidity ⢠Heavy leverage ⢠Weak cash flow PAHC shows solid profitability and strong liquidity, but its high leverage, modest free cash flow, and only fair interest coverage make the risk-reward profile mixed.
Price Behavior
Key Price Behavior Insights: ⢠Downtrend intact ⢠Oversold rebound ⢠Overhead resistance Support Level: $28.40 Resistance Level: $33.50-$34.00 PAHC remains bearish after a last month downtrend and washout to $28.40, but the rebound into the low-$32s hints at a tentative base, so caution stays warranted until it reclaims $34 and then $36.
Sentiment & News
Key News Insights: ⢠Value debate ⢠Growth narrative ⢠Volatility spike PAHC headlines continue to center on valuation debate, long-term growth appeal, and rising near-term trading volatility, with investor interest remaining active but sentiment cautious.
AI Summary
PAHC now looks more like a margin-recovery and operating-leverage story than a simple specialty-pharma name, with raised guidance and improving animal-health mix supporting upside, but the stock likely won't rerate until it proves stronger free-cash-flow conversion and meaningful deleveraging amid regulatory and tariff noise.
Description
Phibro Animal Health Corporation manufactures and sells a range of animal health and mineral nutrition products for livestock, operating through Animal Health, Mineral Nutrition, and Performance Products segments. Its portfolio includes pharmaceutical treatments and vaccines for poultry, swine and cattle, nutritional additives and trace mineral formulations, plus specialty ingredients used in non-food industries. The company distributes products to integrators, feed manufacturers and distributors across North America, Latin America, Europe, the Middle East, Africa and the Asia Pacific from its headquarters in Teaneck, New Jersey.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Sep 2 | Sep 9 | PAHC | Phibro Animal Health Corporation | Phibro Animal Health exhibits strong earnings growth, margin expansion, cash flow strength, and a 42% price surge over the last month, making it a hot short-term idea with a solid fundamental and technical growth profile. | Closed | +12.8% |